• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[具体基因名称]和[具体基因名称]基因多态性在垂体腺瘤中的作用

The role of and gene polymorphisms in pituitary adenoma.

作者信息

Zlatkutė Eglė, Liutkevičienė Rasa, Vilkevičiūtė Alvita, Glebauskienė Brigita, Kriaučiūnienė Loresa, Jakštienė Silvija, Žaliūnienė Dalia

机构信息

Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania.

Neuroscience Institute, Lithuanian University of Health Sciences, Kaunas, Lithuania.

出版信息

Acta Med Litu. 2017;24(4):177-190. doi: 10.6001/actamedica.v24i4.3613.

DOI:10.6001/actamedica.v24i4.3613
PMID:29487481
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5818253/
Abstract

BACKGROUND

The pathogenesis of pituitary adenoma (PA) is complex and poorly understood. It is thought that PA has a multifactorial aetiology; genetic factors also have an impact on PA development. Since and genes play an important role in tumour growth, differentiation and progression, we decided to determine if the frequency of the genotypes of and polymorphisms influence the development of PA.

MATERIALS AND METHODS

The study enrolled = 100 patients with PA and = 200 healthy controls (reference group). The genotyping tests of and were carried out using the real-time polymerase chain reaction (PCR) method.

RESULTS

The polymorphism in the gene 1G/1G genotype was more frequent in the group of invasive PA than in the control group: 28.6% vs. 16.5%, = 0.044. The 1G/2G genotype was more frequent in females of the control group compared to PA group females: 50.3% vs. 30.8%, = 0.011. The polymorphism in the MMP-1 gene 1G/1G genotype was more frequent in the active PA group than in the control group: 28.4% vs. 16.5%, = 0.044. FGFR4-R388 did not play any predominant role in PA development.

CONCLUSION

The gene 1G/1G may play a role in invasive and active PA development.

摘要

背景

垂体腺瘤(PA)的发病机制复杂,目前了解甚少。人们认为PA具有多因素病因;遗传因素也对PA的发生发展有影响。由于 和 基因在肿瘤生长、分化和进展中起重要作用,我们决定确定 和 基因多态性的基因型频率是否会影响PA的发生发展。

材料与方法

该研究纳入了100例PA患者和200例健康对照(参照组)。采用实时聚合酶链反应(PCR)方法进行 和 的基因分型检测。

结果

侵袭性PA组中 基因1G/1G基因型的多态性比对照组更常见:28.6% 对16.5%,P = 0.044。与PA组女性相比,对照组女性中1G/2G基因型更常见:50.3% 对30.8%,P = 0.011。活性PA组中MMP - 1基因1G/1G基因型的多态性比对照组更常见:28.4% 对16.5%,P = 0.044。FGFR4 - R388在PA发生发展中未起任何主要作用。

结论

基因1G/1G可能在侵袭性和活性PA的发生发展中起作用。

相似文献

1
The role of and gene polymorphisms in pituitary adenoma.[具体基因名称]和[具体基因名称]基因多态性在垂体腺瘤中的作用
Acta Med Litu. 2017;24(4):177-190. doi: 10.6001/actamedica.v24i4.3613.
2
Does MMP-9 Gene Polymorphism Play a Role in Pituitary Adenoma Development?基质金属蛋白酶-9基因多态性在垂体腺瘤发生中起作用吗?
Dis Markers. 2017;2017:5839528. doi: 10.1155/2017/5839528. Epub 2017 Jan 17.
3
Role of MMP-2 (-1306 C/T) Polymorphism in Pituitary Adenoma.基质金属蛋白酶-2(-1306 C/T)多态性在垂体腺瘤中的作用
Scientifica (Cairo). 2016;2016:2839697. doi: 10.1155/2016/2839697. Epub 2016 Mar 9.
4
FGF receptor-4 (FGFR4) polymorphism acts as an activity switch of a membrane type 1 matrix metalloproteinase-FGFR4 complex.成纤维细胞生长因子受体 4(FGFR4)多态性作为膜型 1 基质金属蛋白酶-FGFR4 复合物的活性开关。
Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15786-91. doi: 10.1073/pnas.0914459107. Epub 2010 Aug 23.
5
The Association of Promoter Polymorphisms with Breast Cancer.启动子多态性与乳腺癌的关联
In Vivo. 2018 May-Jun;32(3):487-491. doi: 10.21873/invivo.11265.
6
Fibroblast growth factor receptor 4 regulates tumor invasion by coupling fibroblast growth factor signaling to extracellular matrix degradation.成纤维细胞生长因子受体 4 通过将成纤维细胞生长因子信号传递到细胞外基质降解来调节肿瘤侵袭。
Cancer Res. 2010 Oct 15;70(20):7851-61. doi: 10.1158/0008-5472.CAN-10-1223. Epub 2010 Sep 28.
7
Association of (-1,607) 1G/2G polymorphism of matrix metalloproteinase-1 gene with knee osteoarthritis in the Turkish population (knee osteoarthritis and MMPs gene polymorphisms).土耳其人群中基质金属蛋白酶-1基因(-1,607)1G/2G多态性与膝骨关节炎的关联(膝骨关节炎与基质金属蛋白酶基因多态性)
Rheumatol Int. 2009 Feb;29(4):383-8. doi: 10.1007/s00296-008-0705-6. Epub 2008 Sep 20.
8
[Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis].基质金属蛋白酶启动子中的单核苷酸多态性与子宫内膜异位症和子宫腺肌病的易感性相关
Zhonghua Fu Chan Ke Za Zhi. 2005 Sep;40(9):601-4.
9
Matrix metalloproteinase-1 mitral expression and -1607 1G/2G gene promoter polymorphism in mitral chordae tendinae rupture.二尖瓣腱索断裂中基质金属蛋白酶-1 的二尖瓣表达和-1607 1G/2G 基因启动子多态性。
Transl Res. 2013 May;161(5):406-13. doi: 10.1016/j.trsl.2012.10.002. Epub 2012 Oct 29.
10
Matrix metalloproteinase-1 polymorphism (-1607G) and disease severity in non-cystic fibrosis bronchiectasis in Taiwan.基质金属蛋白酶-1 多态性 (-1607G) 与台湾非囊性纤维化支气管扩张症的疾病严重程度。
PLoS One. 2013 Jun 11;8(6):e66265. doi: 10.1371/journal.pone.0066265. Print 2013.

引用本文的文献

1
The Role of Single-Nucleotide Polymorphisms in Pituitary Adenomas Tumorigenesis.单核苷酸多态性在垂体腺瘤肿瘤发生中的作用。
Cancers (Basel). 2019 Dec 9;11(12):1977. doi: 10.3390/cancers11121977.
2
Reduction of miR-212 contributes to pituitary adenoma cell invasion via targeting c-Met.miR-212 的减少通过靶向 c-Met 促进垂体腺瘤细胞侵袭。
Kaohsiung J Med Sci. 2020 Feb;36(2):81-88. doi: 10.1002/kjm2.12137. Epub 2019 Oct 23.
3
Association of PTTG1 polymorphism rs1895320, rs2910200 and rs6882742 with non-functioning pituitary adenomas in Chinese Han population: a case-control study.PTTG1 多态性 rs1895320、rs2910200 和 rs6882742 与中国汉族人群无功能垂体腺瘤的关联:一项病例对照研究。
Metab Brain Dis. 2019 Jun;34(3):841-846. doi: 10.1007/s11011-018-0364-6. Epub 2019 Jan 3.

本文引用的文献

1
Human Schlafen 5 (SLFN5) Is a Regulator of Motility and Invasiveness of Renal Cell Carcinoma Cells.人类 Schlafen 5(SLFN5)是肾癌细胞运动性和侵袭性的调节因子。
Mol Cell Biol. 2015 Aug;35(15):2684-98. doi: 10.1128/MCB.00019-15. Epub 2015 May 26.
2
Overexpression of EpCAM and Trop2 in pituitary adenomas.垂体腺瘤中EpCAM和Trop2的过表达。
Int J Clin Exp Pathol. 2014 Oct 15;7(11):7907-14. eCollection 2014.
3
Expression of matrix metalloproteinases and their inhibitors in different immunohistochemical-based molecular subtypes of breast cancer.基质金属蛋白酶及其抑制剂在基于免疫组织化学的不同乳腺癌分子亚型中的表达
BMC Cancer. 2014 Dec 16;14:959. doi: 10.1186/1471-2407-14-959.
4
Prognostic impact of a compartment-specific angiogenic marker profile in patients with pancreatic cancer.特定区域血管生成标志物谱对胰腺癌患者的预后影响
Oncotarget. 2014 Dec 30;5(24):12978-89. doi: 10.18632/oncotarget.2651.
5
The role of a single nucleotide polymorphism of the matrix metalloproteinase-1 gene promoter region in invasion and prognosis of meningiomas.
Turk Neurosurg. 2014;24(5):731-6. doi: 10.5137/1019-5149.JTN.9823-13.1.
6
Role of interstitial collagenase gene promoter polymorphism in the etiology of gastric cancer.间质胶原酶基因启动子多态性在胃癌病因学中的作用。
Saudi J Gastroenterol. 2014 Sep-Oct;20(5):309-14. doi: 10.4103/1319-3767.141693.
7
The molecular pathogenesis of pituitary adenomas: an update.垂体腺瘤的分子发病机制:最新研究进展。
Endocrinol Metab (Seoul). 2013 Dec;28(4):245-54. doi: 10.3803/EnM.2013.28.4.245.
8
The role of MMP-1 in breast cancer growth and metastasis to the brain in a xenograft model.基质金属蛋白酶-1 在异种移植模型中对乳腺癌生长和脑转移的作用。
BMC Cancer. 2012 Dec 7;12:583. doi: 10.1186/1471-2407-12-583.
9
The FGFR4-G388R polymorphism promotes mitochondrial STAT3 serine phosphorylation to facilitate pituitary growth hormone cell tumorigenesis.FGFR4-G388R 多态性促进线粒体 STAT3 丝氨酸磷酸化,促进垂体生长激素细胞瘤的发生。
PLoS Genet. 2011 Dec;7(12):e1002400. doi: 10.1371/journal.pgen.1002400. Epub 2011 Dec 8.
10
Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor.FGFR4 Gly388Arg 多态性作为癌症预后因素的荟萃和 pooled 分析。
Eur J Cancer Prev. 2011 Jul;20(4):340-7. doi: 10.1097/CEJ.0b013e3283457274.